Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Referral Center for Demyelinating Diseases of the Central Nervous System, University Department of Neurology, Zagreb School of Medicine and University Hospital Center, Kišpatićeva 12, 10000 Zagreb, Croatia. mhabek@mef.hr
Mario
M
Habek
Ivan
I
Adamec
Tereza
T
Gabelić
Vesna V
VV
Brinar
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005155:Facial Nerve Diseases / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications / Q000473:pathology*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D011149:Pons / Q000473:pathology*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A